Casey Woodring
Stock Analyst at JP Morgan
(0.32)
# 3,994
Out of 4,818 analysts
32
Total ratings
15%
Success rate
-21.39%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $27.79 | -10.04% | 4 | Apr 21, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $114.11 | +44.60% | 7 | Feb 20, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $280 → $265 | $145.82 | +81.73% | 5 | Feb 3, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $58.29 | +61.26% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $42.92 | +29.59% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $3.02 | +99.00% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $18.77 | +22.54% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $11.19 | +60.86% | 2 | Jan 23, 2023 |
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $27.79
Upside: -10.04%
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $114.11
Upside: +44.60%
ICON Public Limited Company
Feb 3, 2025
Maintains: Overweight
Price Target: $280 → $265
Current: $145.82
Upside: +81.73%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $58.29
Upside: +61.26%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $42.92
Upside: +29.59%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $3.02
Upside: +99.00%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $18.77
Upside: +22.54%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $11.19
Upside: +60.86%